In 2023, Gaurav Shah earned $638.57K in total compensation at Rocket Pharmaceuticals, primarily from $625.00K salary. Most recently acquired 163,310 shares in Feb 2025. Currently holds stock worth $3.27M. Has donated $1.35M in stock to charitable causes. 7+ years at the helm of Rocket Pharmaceuticals.
Compensation History
Annual executive compensation data for Gaurav Shah, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$638.57K
Salary
$625.00K
Bonus
$0.00
Other
$13.57K
Salary
$625.00KBoard Justification
The compensation program is designed to attract, motivate, and retain executive talent while aligning compensation with company performance and shareholder value.
Bonus
$0.00Board Justification
No bonus was awarded for fiscal 2023.
Other Compensation
$13.57KBoard Justification
Other compensation includes company matching contributions to the 401(k) plan and life insurance costs.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus was on stock options and RSUs that are yet to vest.
Performance Metrics
Performance metrics for fiscal 2023 included achieving corporate objectives related to clinical development and maintaining a strong reputation.
Gaurav Shah
CEO of Rocket Pharmaceuticals
Education
M.D. from Columbia University
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1975 - 50 years ago
CEO of Rocket Pharmaceuticals for
7 years 11 months (Jan 2018 - Present)
Previous Experience
Global Program Head for CART-19 at Novartis
Holdings
Track Gaurav Shah's stock holdings and portfolio value over time.
Total Stock Sold
$2.99M
$2.99M
157,877 RCKT shares
What if they kept their stock?
If Gaurav Shah didn't sell their stock, today they would have:
Extra RCKT157,877 shares worth $524.15K.
This is -82.47% and $2.47M less than what they got when they sold the stock.
Charitable Transactions
406,238 shares
RCKT
Recent Charitable Transactions
406,238 shares
RCKT
Dec 31, 2020
Charity
Insider Trading
Gaurav Shah's recent stock transactions, purchases, and sales filed with the SEC.
163,310 shares
RCKT
Feb 11, 2025
Received
$289.56K
RCKT at $13.05/share
Nov 21, 2024
Sale
$178.56K
RCKT at $18.50/share
Aug 16, 2024
Sale
$228.60K
RCKT at $23.35/share
May 14, 2024
Sale
66,577 shares
RCKT
Feb 16, 2024
Received
$604.88K
RCKT at $29.84/share
Feb 16, 2024
Sale
$73.75K
RCKT at $15.47/share
Aug 17, 2023
Sale
$88.11K
RCKT at $21.38/share
May 17, 2023
Sale
$232.42K
RCKT at $19.06/share
Feb 17, 2023
Sale
$381.51K
RCKT at $17.34/share
Feb 7, 2022
Purchase
Rivals
Compare Gaurav Shah with competitor CEOs and industry peers.